Skip to main content
Erschienen in: Pediatric Cardiology 7/2014

01.10.2014 | Original Article

Prevalence of Deficient Retro-Aortic Rim and Its Effects on Outcomes in Device Closure of Atrial Septal Defects

verfasst von: Michael L. O’Byrne, Andrew C. Glatz, Sherzana Sunderji, Aswathi E. Mathew, David J. Goldberg, Yoav Dori, Jonathan J. Rome, Matthew J. Gillespie

Erschienen in: Pediatric Cardiology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Deficient retro-aortic rim is of concern as a risk factor for aortic erosion after device closure of atrial septal defects (ASD). However, its prevalence and contribution to technical failure and adverse outcomes have not been delineated. A single-center retrospective cohort study of children and adults undergoing cardiac catheterization for device occlusion of ASD from 1 January 1999 to 1 April 2012 was performed. Risk factors for technical failure and early adverse outcome were assessed using multivariate logistic regression. During the study period, 445 consecutive subjects with a median age of 5.9 years (range, 0.8–80 years) underwent catheterization. Of the subjects with reviewable echocardiograms, 60 % had deficient retro-aortic rim. No attempt at device closure was made for 3.6 % of the subjects. Of the remaining 429 subjects, 96 % underwent successful device occlusion. Major early adverse events occurred in 1.2 % (95 % confidence interval 0.4–2.7 %) of the cases, all of them either device embolization or malposition. Deficient retro-aortic rim was not a risk factor for composite outcome of technical failure or early major adverse event. No deaths, late reinterventions, or erosion events occurred during 2,395 total person-years (median, 5.8 years) of follow-up evaluation. Deficient retro-aortic rim was associated with increased risk of device impingement on the aorta, but no association was seen between device impingement or deficient retro-aortic rim and the development of new/progressive aortic insufficiency. Deficient retro-aortic rim is highly prevalent but did not increase the risk of adverse outcomes. Its contribution to the risk of aortic erosion could not be addressed by this study.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abdullah Al-Qbandi MH, Hijazi ZM (2010) Device closure of difficult ASDs. In: Hijazi ZM, Feldman T, Abdullah Al-Qbandi MH, Sievert H (eds) Transcatheter closure of ASDs and PFOs: a comprehensive assessment. Cardiotext, Minneapolis, MN, pp 177–195 Abdullah Al-Qbandi MH, Hijazi ZM (2010) Device closure of difficult ASDs. In: Hijazi ZM, Feldman T, Abdullah Al-Qbandi MH, Sievert H (eds) Transcatheter closure of ASDs and PFOs: a comprehensive assessment. Cardiotext, Minneapolis, MN, pp 177–195
3.
Zurück zum Zitat Amin Z (2013) Echocardiographic predictors of cardiac erosion after amplatzer septal occluder placement. Catheter Cardiovasc Interv. doi:10.1002/ccd.25175 Amin Z (2013) Echocardiographic predictors of cardiac erosion after amplatzer septal occluder placement. Catheter Cardiovasc Interv. doi:10.​1002/​ccd.​25175
4.
Zurück zum Zitat Amin Z, Hijazi ZM, Bass JL et al (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Cathet Cardiovasc Intervent 63:496–502. doi:10.1002/ccd.20211 CrossRef Amin Z, Hijazi ZM, Bass JL et al (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Cathet Cardiovasc Intervent 63:496–502. doi:10.​1002/​ccd.​20211 CrossRef
5.
Zurück zum Zitat (2012) Amplatzer Septal Occluder and Delivery System: Instructions for Use. professionalsjmcom 1–16 (2012) Amplatzer Septal Occluder and Delivery System: Instructions for Use. professionalsjmcom 1–16
8.
Zurück zum Zitat Butera G, Biondi-Zoccai G, Sangiorgi G et al (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7:377–385. doi:10.4244/EIJV7I3A63 CrossRefPubMed Butera G, Biondi-Zoccai G, Sangiorgi G et al (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7:377–385. doi:10.​4244/​EIJV7I3A63 CrossRefPubMed
9.
Zurück zum Zitat Chessa M, Carminati M, Butera G et al (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. JAC 39:1061–1065CrossRef Chessa M, Carminati M, Butera G et al (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. JAC 39:1061–1065CrossRef
10.
Zurück zum Zitat Delaney JW, Li JS, Rhodes JF (2007) Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the Manufacturer and User Facility Device Experience (MAUDE) database. Congenit Heart Dis 2:1–9CrossRef Delaney JW, Li JS, Rhodes JF (2007) Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the Manufacturer and User Facility Device Experience (MAUDE) database. Congenit Heart Dis 2:1–9CrossRef
11.
Zurück zum Zitat Diab K, Kenny D, Hijazi ZM (2012) Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe? Cathet Cardiovasc Intervent 80:168–174. doi:10.1002/ccd.24517 CrossRef Diab K, Kenny D, Hijazi ZM (2012) Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe? Cathet Cardiovasc Intervent 80:168–174. doi:10.​1002/​ccd.​24517 CrossRef
13.
Zurück zum Zitat DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr (2009) Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137:1334–1341. doi:10.1016/j.jtcvs.2009.02.032 PubMedCentralCrossRefPubMed DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr (2009) Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137:1334–1341. doi:10.​1016/​j.​jtcvs.​2009.​02.​032 PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Du ZD, Hijazi ZM, Kleinman CS et al (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. JAC 39:1836–1844CrossRef Du ZD, Hijazi ZM, Kleinman CS et al (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. JAC 39:1836–1844CrossRef
15.
Zurück zum Zitat FDA (2013) Rare serious erosion events associated with St. Jude Amplatzer atrial septal occluder (ASO). United States Food and Drug Administration, Silver Spring, MD FDA (2013) Rare serious erosion events associated with St. Jude Amplatzer atrial septal occluder (ASO). United States Food and Drug Administration, Silver Spring, MD
16.
Zurück zum Zitat King TD, Thompson SL, Steiner C, Mills NL (1976) Secundum atrial septal defect: nonoperative closure during cardiac catheterization. JAMA 235:2506–2509CrossRefPubMed King TD, Thompson SL, Steiner C, Mills NL (1976) Secundum atrial septal defect: nonoperative closure during cardiac catheterization. JAMA 235:2506–2509CrossRefPubMed
17.
18.
Zurück zum Zitat Latson LA, Jones TK, Jacobson J et al (2006) Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the Helex septal occluder. Am Heart J 151:1129.e7–1129.e11. doi:10.1016/j.ahj.2006.01.005 CrossRef Latson LA, Jones TK, Jacobson J et al (2006) Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the Helex septal occluder. Am Heart J 151:1129.e7–1129.e11. doi:10.​1016/​j.​ahj.​2006.​01.​005 CrossRef
20.
Zurück zum Zitat Mahapatra S, Graves AM (2013) Letter to physicians. professionalsjmcom 1–2 Mahapatra S, Graves AM (2013) Letter to physicians. professionalsjmcom 1–2
21.
Zurück zum Zitat Mallula K, Amin Z (2012) Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol 33:995–1000. doi:10.1007/s00246-012-0323-7 CrossRefPubMed Mallula K, Amin Z (2012) Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol 33:995–1000. doi:10.​1007/​s00246-012-0323-7 CrossRefPubMed
23.
24.
Zurück zum Zitat Sun GW, Shook TL, Kay GL (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49:907–916CrossRefPubMed Sun GW, Shook TL, Kay GL (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49:907–916CrossRefPubMed
25.
Zurück zum Zitat Vincent RN, Raviele AA, Diehl HJ (2003) Single-center experience with the Helex septal occluder for closure of atrial septal defects in children. J Intervent Cardiol 16:79–82CrossRefPubMed Vincent RN, Raviele AA, Diehl HJ (2003) Single-center experience with the Helex septal occluder for closure of atrial septal defects in children. J Intervent Cardiol 16:79–82CrossRefPubMed
26.
Zurück zum Zitat Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE (2012) Predictor selection. In: Regression methods in biostatistics: linear, logistic, survival, and repeated measures models, 2nd ed. Springer, New York, pp 395–429 Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE (2012) Predictor selection. In: Regression methods in biostatistics: linear, logistic, survival, and repeated measures models, 2nd ed. Springer, New York, pp 395–429
Metadaten
Titel
Prevalence of Deficient Retro-Aortic Rim and Its Effects on Outcomes in Device Closure of Atrial Septal Defects
verfasst von
Michael L. O’Byrne
Andrew C. Glatz
Sherzana Sunderji
Aswathi E. Mathew
David J. Goldberg
Yoav Dori
Jonathan J. Rome
Matthew J. Gillespie
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2014
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-014-0914-6

Weitere Artikel der Ausgabe 7/2014

Pediatric Cardiology 7/2014 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.